Badgley Phelps Wealth Managers, LLC
Source: SEC Form 13F · as of Mar 2026Badgley Phelps Wealth Managers, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $220.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$220.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 93,356 | $85.9M |
| JNJJOHNSON & JOHNSON | 160,944 | $39.3M |
| MCKMcKesson Corporation | 30,835 | $26.7M |
| GILDGILEAD SCIENCES, INC. | 122,271 | $17.0M |
| MRKMerck & Co., Inc. | 131,499 | $15.9M |
| GEHCGE HealthCare Technologies Inc. | 120,221 | $8.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 21,232 | $5.7M |
| AMGNAMGEN INC | 14,336 | $5.0M |
| ABBVAbbVie Inc. | 15,615 | $3.4M |
| OMEROMEROS CORP | 263,556 | $2.8M |
| ABTABBOTT LABORATORIES | 17,558 | $1.8M |
| BMYBRISTOL MYERS SQUIBB CO | 27,117 | $1.6M |
| PFEPFIZER INC | 57,172 | $1.6M |
| PMPhilip Morris International Inc | 9,256 | $1.5M |
| ZTSZoetis Inc. | 10,096 | $1.2M |
| GMOptec International, Inc. | 11,653 | $868K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,881 | $840K |
| CORCencora Inc. | 949 | $298K |
| NVSNovartis AG | 1,713 | $262K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.